
<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-4.xsd">
    
    <titleInfo>
        <title>Co-enrollment in multiple HIV prevention trials â€” Experiences from the CAPRISA 004 Tenofovir gel trial</title>
    </titleInfo>
    <name type="personal" ID="qa4">
        <namePart type="family">Abdool Karim</namePart>
        <namePart type="given">Quarraisha</namePart>
        <role>
            <roleTerm type="text">author</roleTerm>
        </role>
        <affiliation>Columbia University. Epidemiology</affiliation>
    </name>
    <name type="personal">
        <namePart type="family">Kharsany</namePart>
        <namePart type="given">Ayesha B. M.</namePart>
        <role>
            <roleTerm type="text">author</roleTerm>
        </role>
    </name>
    <name type="personal">
        <namePart type="family">Naidoo</namePart>
        <namePart type="given">Kasavan</namePart>
        <role>
            <roleTerm type="text">author</roleTerm>
        </role>
    </name>
    <name type="personal">
        <namePart type="family">Yende</namePart>
        <namePart type="given">Nonhlanhla</namePart>
        <role>
            <roleTerm type="text">author</roleTerm>
        </role>
    </name>
    <name type="personal">
        <namePart type="family">Gengiah</namePart>
        <namePart type="given">Tanuja N.</namePart>
        <role>
            <roleTerm type="text">author</roleTerm>
        </role>
    </name>
    <name type="personal">
        <namePart type="family">Omar</namePart>
        <namePart type="given">Zaheen</namePart>
        <role>
            <roleTerm type="text">author</roleTerm>
        </role>
    </name>
    <name type="personal">
        <namePart type="family">Arulappan</namePart>
        <namePart type="given">Natasha</namePart>
        <role>
            <roleTerm type="text">author</roleTerm>
        </role>
    </name>
    <name type="personal">
        <namePart type="family">Mlisana</namePart>
        <namePart type="given">Koleka P.</namePart>
        <role>
            <roleTerm type="text">author</roleTerm>
        </role>
    </name>
    <name type="personal">
        <namePart type="family">Luthuli</namePart>
        <namePart type="given">Londiwe R.</namePart>
        <role>
            <roleTerm type="text">author</roleTerm>
        </role>
    </name>
    <name type="personal" ID="ssa16">
        <namePart type="family">Abdool Karim</namePart>
        <namePart type="given">Salim</namePart>
        <role>
            <roleTerm type="text">author</roleTerm>
        </role>
        <affiliation>Columbia University. Epidemiology</affiliation>
    </name>
    <name type="corporate">
        <namePart>Columbia University. Epidemiology</namePart>
        <role>
            <roleTerm type="text">originator</roleTerm>
        </role>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre>Articles</genre>
    
    <originInfo>
        <dateIssued encoding="w3cdtf" keyDate="yes">2011</dateIssued>
    </originInfo>
    
    <language>
        <languageTerm type="text">English</languageTerm>
    </language>
    <abstract>Background: In settings where multiple HIV prevention trials are conducted in close proximity, trial participants may attempt to enroll in more than one trial simultaneously. Co-enrollment impacts on participant&apos;s safety and validity of trial results. We describe our experience, remedial action taken, inter-organizational collaboration and lessons learnt following the identification of co-enrolled participants. Experiences: Between February and April 2008, we identified 185 of the 398 enrolled participants as ineligible. In violation of the study protocol exclusion criteria, there was simultaneous enrollment in another HIV prevention trial (ineligible co-enrolled, n = 135), and enrollment of women who had participated in a microbicide trial within the past 12 months (ineligible not co-enrolled, n = 50). Following a complete audit of all enrolled participants, ineligible participants were discontinued via study exit visits from trial follow-up. Custom-designed education program on co-enrollment impacting on participants&apos; safety and validity of the trial results was implemented. Shared electronic database between research units was established to enable verification of each volunteer&apos;s trial participation and to prevent future co-enrollments. Lessons learnt: Interviews with ineligible enrolled women revealed that high-quality care, financial incentives, altruistic motives, preference for sex with gel, wanting to increase their likelihood of receiving active gel, perceived low risk of discovery and peer pressure are the reasons for their enrollment in the CAPRISA 004 trial. Conclusion: Instituting education programs based on the reasons reported by women for seeking enrollment in more than one trial and using a shared central database system to identify co-enrollments have effectively prevented further co-enrollments.</abstract>
    <subject>
        <topic>Virology</topic>
    </subject>
    <subject>
        <topic>Epidemiology</topic>
    </subject>
    <relatedItem type="host">
        <titleInfo>
            <title>Contemporary Clinical Trials</title>
        </titleInfo>
        <part>
            <detail type="volume">
                <number>32</number>
            </detail>
            <detail type="issue">
                <number>3</number>
            </detail>
            <extent unit="page">
                <start>333</start>
                <end>338</end>
            </extent>
            <date>2011-05</date>
        </part>
        <identifier type="doi">http://dx.doi.org/10.1016/j.cct.2011.01.005</identifier>
    </relatedItem>
    <identifier type="hdl">http://hdl.handle.net/10022/AC:P:12484</identifier>
    
    <location>
        <physicalLocation authority="marcorg">NNC</physicalLocation>
    </location>
    
    <recordInfo>
        <recordContentSource authority="marcorg">NNC</recordContentSource>
        <recordCreationDate encoding="w3cdtf">2012-02-07 13:15:56 -0500</recordCreationDate>
        <recordChangeDate encoding="w3cdtf">2012-08-02 11:43:29 -0400</recordChangeDate>
        <recordIdentifier>6486</recordIdentifier>
        <languageOfCataloging>
            <languageTerm authority="iso639-2b">eng</languageTerm>
        </languageOfCataloging>
    </recordInfo>
    
</mods>
